Clearstead Advisors’s GoodRx Holdings GDRX Stock Holding History

Clearstead Advisors’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$214	Buy	+74	New	+$188	﹤0.01%	3187
2026 Q1	–	Sell	-10	Closed	-$28	–	2483
2025 Q4	$28	Sell	10 -22	-69%	-$72	﹤0.01%	2662
2025 Q3	$136	Sell	32 -168	-84%	-$739	﹤0.01%	2900
2025 Q2	$996	Hold	200	–	–	﹤0.01%	2434
2025 Q1	$882	Hold	200	–	–	﹤0.01%	2000
2024 Q4	$930	Hold	200	–	–	﹤0.01%	1930
2024 Q3	$1.39K	Hold	200	–	–	﹤0.01%	1873
2024 Q2	$1.56K	Hold	200	–	–	﹤0.01%	1845
2024 Q1	$1.34K	Buy	+200	New	+$1.32K	﹤0.01%	1370
2023 Q2	–	Sell	-100	Closed	-$625	–	1403
2023 Q1	$625	Hold	100	–	–	﹤0.01%	1280
2022 Q4	$466	Sell	100 -40	-29%	-$197	﹤0.01%	1237
2022 Q3	$1K	Hold	140	–	–	﹤0.01%	1148
2022 Q2	$1K	Hold	140	–	–	﹤0.01%	1183
2022 Q1	$3K	Hold	140	–	–	﹤0.01%	1144
2021 Q4	$5K	Buy	140 +10	+8%	+$402	﹤0.01%	995
2021 Q3	$5K	Hold	130	–	–	﹤0.01%	1020
2021 Q2	$5K	Buy	130 +30	+30%	+$1.11K	﹤0.01%	881
2021 Q1	$4K	Buy	+100	New	+$4.5K	﹤0.01%	886

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $361M AUM 30.56% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SLG

Silver Lake Group Menlo Park, California $4.58B AUM 24.86% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

PTC

Petrus Trust Company Dallas, Texas $1.06B AUM 4.66% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Clearstead Advisors's GDRX Position: Q2 2026 in Review

Clearstead Advisors opened a new position in GoodRx Holdings (GDRX) in Q2 2026: 74 shares worth $214. The stake represents ﹤0.01% of the portfolio and ranks #3187 among its holdings. This is a return to the name: Clearstead Advisors previously reported a position in GDRX as recently as Q4 2025.

Clearstead Advisors first reported a position in GDRX in Q1 2021 and has held it in 18 quarters since. The position peaked at $5K in Q4 2021. 162 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

Clearstead Advisors held 74 shares of GoodRx Holdings worth $214 as of Q2 2026.
GoodRx Holdings was a new Clearstead Advisors position in Q2 2026.
GoodRx Holdings made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #3187 holding.
Clearstead Advisors first reported a position in GoodRx Holdings in Q1 2021 and has held it in 18 quarters since.
Clearstead Advisors's GoodRx Holdings position peaked at $5K in Q4 2021.
162 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.